Antibiotic and Heavy Metal Susceptibility of Bacteria Isolated from Heavy Metals Contaminated Soil
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Tesis Doctoral 2014 Filogenia Y Evolución De Las Poblaciones Ambientales Y Clínicas De Pseudomonas Stutzeri Y Otras Especies
TESIS DOCTORAL 2014 FILOGENIA Y EVOLUCIÓN DE LAS POBLACIONES AMBIENTALES Y CLÍNICAS DE PSEUDOMONAS STUTZERI Y OTRAS ESPECIES RELACIONADAS Claudia A. Scotta Botta TESIS DOCTORAL 2014 Programa de Doctorado de Microbiología Ambiental y Biotecnología FILOGENIA Y EVOLUCIÓN DE LAS POBLACIONES AMBIENTALES Y CLÍNICAS DE PSEUDOMONAS STUTZERI Y OTRAS ESPECIES RELACIONADAS Claudia A. Scotta Botta Director/a: Jorge Lalucat Jo Director/a: Margarita Gomila Ribas Director/a: Antonio Bennasar Figueras Doctor/a por la Universitat de les Illes Balears Index Index ……………………………………………………………………………..... 5 Acknowledgments ………………………………………………………………... 7 Abstract/Resumen/Resum ……………………………………………………….. 9 Introduction ………………………………………………………………………. 15 I.1. The genus Pseudomonas ………………………………………………….. 17 I.2. The species P. stutzeri ………………………………………………......... 23 I.2.1. Definition of the species …………………………………………… 23 I.2.2. Phenotypic properties ………………………………………………. 23 I.2.3. Genomic characterization and phylogeny ………………………….. 24 I.2.4. Polyphasic identification …………………………………………… 25 I.2.5. Natural transformation ……………………………………………... 26 I.2.6. Pathogenicity and antibiotic resistance …………………………….. 26 I.3. Habitats and ecological relevance ………………………………………… 28 I.3.1. Role of mobile genetic elements …………………………………… 28 I.4. Methods for studying Pseudomonas taxonomy …………………………... 29 I.4.1. Biochemical test-based identification ……………………………… 30 I.4.2. Gas Chromatography of Cellular Fatty Acids ................................ 32 I.4.3. Matrix Assisted Laser-Desorption Ionization Time-Of-Flight -
Uncommon Pathogens Causing Hospital-Acquired Infections in Postoperative Cardiac Surgical Patients
Published online: 2020-03-06 THIEME Review Article 89 Uncommon Pathogens Causing Hospital-Acquired Infections in Postoperative Cardiac Surgical Patients Manoj Kumar Sahu1 Netto George2 Neha Rastogi2 Chalatti Bipin1 Sarvesh Pal Singh1 1Department of Cardiothoracic and Vascular Surgery, CN Centre, All Address for correspondence Manoj K Sahu, MD, DNB, Department India Institute of Medical Sciences, Ansari Nagar, New Delhi, India of Cardiothoracic and Vascular Surgery, CTVS office, 7th floor, CN 2Infectious Disease, Department of Medicine, All India Institute of Centre, All India Institute of Medical Sciences, New Delhi-110029, Medical Sciences, Ansari Nagar, New Delhi, India India (e-mail: [email protected]). J Card Crit Care 2020;3:89–96 Abstract Bacterial infections are common causes of sepsis in the intensive care units. However, usually a finite number of Gram-negative bacteria cause sepsis (mostly according to the hospital flora). Some organisms such as Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus are relatively common. Others such as Stenotrophomonas maltophilia, Chryseobacterium indologenes, Shewanella putrefaciens, Ralstonia pickettii, Providencia, Morganella species, Nocardia, Elizabethkingia, Proteus, and Burkholderia are rare but of immense importance to public health, in view of the high mortality rates these are associated with. Being aware of these organisms, as the cause of hospital-acquired infections, helps in the prevention, Keywords treatment, and control of sepsis in the high-risk cardiac surgical patients including in ► uncommon pathogens heart transplants. Therefore, a basic understanding of when to suspect these organ- ► hospital-acquired isms is important for clinical diagnosis and initiating therapeutic options. This review infection discusses some rarely appearing pathogens in our intensive care unit with respect to ► cardiac surgical the spectrum of infections, and various antibiotics that were effective in managing intensive care unit these bacteria. -
2021 ECCMID | 00656 in Vitro Activities of Ceftazidime-Avibactam and Comparator Agents Against Enterobacterales
IHMA In Vitro Activities of Ceftazidime-avibactam and Comparator Agents against Enterobacterales and 2122 Palmer Drive 00656 Schaumburg, IL 60173 USA Pseudomonas aeruginosa from Israel Collected Through the ATLAS Global Surveillance Program 2013-2019 www.ihma.com M. Hackel1, M. Wise1, G. Stone2, D. Sahm1 1IHMA, Inc., Schaumburg IL, USA, 2Pfizer Inc., Groton, CT USA Introduction Results Results Summary Avibactam (AVI) is a non-β- Table 1 Distribution of 2,956 Enterobacterales from Israel by species Table 2. In vitro activity of ceftazidime-avibactam and comparators agents Figure 2. Ceftazidime and ceftazidime-avibactam MIC distribution against 29 . Ceftazidime-avibactam exhibited a potent lactam, β-lactamase inhibitor against Enterobacterales and P. aeruginosa from Israel, 2013-2019 non-MBL carbapenem-nonsusceptible (CRE) Enterobacterales from Israel, antimicrobial activity higher than all Organism N % of Total mg/L that can restore the activity of Organism Group (N) %S 2013-2019 comparator agents against all Citrobacter amalonaticus 2 0.1% MIC90 MIC50 Range ceftazidime (CAZ) against Enterobacterales (2956) 20 Enterobacterales from Israel (MIC90, 0.5 Citrobacter braakii 5 0.2% Ceftazidime-avibactam 99.8 0.5 0.12 ≤0.015 - > 128 Ceftazidime Ceftazidime-avibactam organisms that possess Class 18 mg/L; 99.8% susceptible). Citrobacter freundii 96 3.2% Ceftazidime 70.1 64 0.25 ≤0.015 - > 128 A, C, and some Class D β- Cefepime 71.8 > 16 ≤0.12 ≤0.12 - > 16 16 . Susceptibility to ceftazidime-avibactam lactmase enzymes. This study Citrobacter gillenii 1 <0.1% Meropenem 98.8 0.12 ≤0.06 ≤0.06 - > 8 increased to 100% for the Enterobacterales Amikacin 95.4 8 2 ≤0.25 - > 32 14 examined the in vitro activity Citrobacter koseri 123 4.2% when MBL-positive isolates were removed Colistin (n=2544)* 82.2 > 8 0.5 ≤0.06 - > 8 12 of CAZ-AVI and comparators Citrobacter murliniae 1 <0.1% Piperacillin-tazobactam 80.4 32 2 ≤0.12 - > 64 from analysis. -
경추 척수 손상 환자에서 발생한 Providencia Rettgeri 패혈증 1예 조현정·임승진·천승연·박권오·이상호·박종원·이진서·엄중식 한림대학교 의과대학 내과학교실
Case Report Infection & DOI: 10.3947/ic.2010.42.6.428 Chemotherapy Infect Chemother 2010;42(6):428-430 경추 척수 손상 환자에서 발생한 Providencia rettgeri 패혈증 1예 조현정·임승진·천승연·박권오·이상호·박종원·이진서·엄중식 한림대학교 의과대학 내과학교실 A Case of Providencia rettgeri Sepsis in a Patient with Hyun-Jung Cho, Seung-Jin Lim, Seung-Yeon Chun, Cervical Cord Injury Kwon-Oh Park, Sang-Ho Lee, Jong-Won Park, Jin- Seo Lee, and Joong-Sik Eom Providencia rettgeri is a member of Enterobacteriacea that is known to cause Department of Internal Medicine, Hallym Univer- urinary tract infection (UTI), septicemia, and wound infections, especially in sity College of Medi cine, Seoul, Korea immunocompromised patients and in those with indwelling urinary catheters. We experienced a case of UTI sepsis by Providencia rettgeri in a patient with spinal cord injury. The patient had only high fever without urinary symptoms or signs after high dose intravenous methylprednisolone. The laboratory results showed leukocytosis (21,900/μL, segmented neutrophils 91.1%) and pyuria. Cefepime was given empirically and it was switched to oral trimethoprim-sulfamethoxazole because P. rettgeri was identified from blood and urine culture which was susceptible to TMP-SMX. The patient was improved clinically but P. rettgeri was not eradicated microbiologically. To the best of our knowledge, this is the first case report on sepsis caused by Providencia rettgeri in Korea. Key Words: Providencia rettgeri, Sepsis, Urinary tract infection Introduction The genus Providencia is a member of the Enterobacteriaceae family which commonly dwells in soil, water, and sewage [1, 2]. Providencia rettgeri is one of five Providencia species that is known to cause various infections, especially the Copyright © 2010 by The Korean Society of Infectious Diseases | Korean urinary tract infection (UTI) [3]. -
The LOUISIANA ANTIBIOGRAM Louisiana Antibiotic Resistance 2014
The LOUISIANA ANTIBIOGRAM Louisiana Antibiotic Trends in Antibiotic Resistance Resistance 2014 in Louisiana 2008 Zahidul Islam MBBS, MPH, Raoult C Ratard MD MPH Contributors to this report: Lauren Kleamenakis MPH, Anup Subedee MD MPH and Raoult Ratard MD MPH. This report covers bacteria causing severe human infections and the antibiotics used to treat those infections. Resistance to other antimicrobials (antivirals, antifungals and anti-parasitic drugs) are not included for lack of systematic reporting and collection of comprehensive data. Contents 1-Introduction ............................................................................................................................................... 3 1.1-Bacterial resistance to antibiotics is a major threat to human health .................................................. 3 1.2-Tracking resistance patterns is a major action in the fight against antibiotic resistance ..................... 3 2-Methods ..................................................................................................................................................... 3 2.1-Active surveillance .............................................................................................................................. 3 2.2-Antibiogram collection ....................................................................................................................... 3 2.3-Analysis .............................................................................................................................................. -
Table S5. the Information of the Bacteria Annotated in the Soil Community at Species Level
Table S5. The information of the bacteria annotated in the soil community at species level No. Phylum Class Order Family Genus Species The number of contigs Abundance(%) 1 Firmicutes Bacilli Bacillales Bacillaceae Bacillus Bacillus cereus 1749 5.145782459 2 Bacteroidetes Cytophagia Cytophagales Hymenobacteraceae Hymenobacter Hymenobacter sedentarius 1538 4.52499338 3 Gemmatimonadetes Gemmatimonadetes Gemmatimonadales Gemmatimonadaceae Gemmatirosa Gemmatirosa kalamazoonesis 1020 3.000970902 4 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sphingomonas indica 797 2.344876284 5 Firmicutes Bacilli Lactobacillales Streptococcaceae Lactococcus Lactococcus piscium 542 1.594633558 6 Actinobacteria Thermoleophilia Solirubrobacterales Conexibacteraceae Conexibacter Conexibacter woesei 471 1.385742446 7 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sphingomonas taxi 430 1.265115184 8 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sphingomonas wittichii 388 1.141545794 9 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sphingomonas sp. FARSPH 298 0.876754244 10 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sorangium cellulosum 260 0.764953367 11 Proteobacteria Deltaproteobacteria Myxococcales Polyangiaceae Sorangium Sphingomonas sp. Cra20 260 0.764953367 12 Proteobacteria Alphaproteobacteria Sphingomonadales Sphingomonadaceae Sphingomonas Sphingomonas panacis 252 0.741416341 -
Understanding the Composition and Role of the Prokaryotic Diversity in the Potato Rhizosphere for Crop Improvement in the Andes
Understanding the composition and role of the prokaryotic diversity in the potato rhizosphere for crop improvement in the Andes Jonas Ghyselinck Dissertation submitted in fulfilment of the requirements for the degree of Doctor (Ph.D.) in Sciences, Biotechnology Promotor - Prof. Dr. Paul De Vos Co-promotor - Dr. Kim Heylen Ghyselinck Jonas – Understanding the composition and role of the prokaryotic diversity in the potato rhizosphere for crop improvement in the Andes Copyright ©2013 Ghyselinck Jonas ISBN-number: 978-94-6197-119-7 No part of this thesis protected by its copyright notice may be reproduced or utilized in any form, or by any means, electronic or mechanical, including photocopying, recording or by any information storage or retrieval system without written permission of the author and promotors. Printed by University Press | www.universitypress.be Ph.D. thesis, Faculty of Sciences, Ghent University, Ghent, Belgium. This Ph.D. work was financially supported by European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement N° 227522 Publicly defended in Ghent, Belgium, May 28th 2013 EXAMINATION COMMITTEE Prof. Dr. Savvas Savvides (chairman) Faculty of Sciences Ghent University, Belgium Prof. Dr. Paul De Vos (promotor) Faculty of Sciences Ghent University, Belgium Dr. Kim Heylen (co-promotor) Faculty of Sciences Ghent University, Belgium Prof. Dr. Anne Willems Faculty of Sciences Ghent University, Belgium Prof. Dr. Peter Dawyndt Faculty of Sciences Ghent University, Belgium Prof. Dr. Stéphane Declerck Faculty of Biological, Agricultural and Environmental Engineering Université catholique de Louvain, Louvain-la-Neuve, Belgium Dr. Angela Sessitsch Department of Health and Environment, Bioresources Unit AIT Austrian Institute of Technology GmbH, Tulln, Austria Dr. -
Figure S1 Supplementary Figure 1. Phylogenetic Tree for Reb
Figure S1 Shewanella denitrificans OS217-reb1 Plesiocystis pacifica SIR-1-reb8 Polymorphum gilvum SL003B-26A1-reb1 Xanthomonas axonopodis pv. citri str. 306-reb6 Plesiocystis pacifica SIR-1-reb6 Azorhizobium caulinodans-reb3 Rhodospirillum centenum-reb1 Azorhizobium caulinodans-reb1 Plesiocystis pacifica SIR-1-reb3 Rhodospirillum centenum-reb2 Rhodospirillum centenum-reb5 Rhodospirillum centenum-reb4 Burkholderia ambifaria AMMD-reb2 Burkholderia ambifaria AMMD-reb1 Burkholderia ambifaria AMMD-reb3 Rhodospirillum centenum-reb3 Burkholderia lata-383 Plesiocystis pacifica SIR-1-reb5 Azorhizobium caulinodans-reb2 Plesiocystis pacifica SIR-1-reb4 Azorhizobium caulinodans-reb4 Plesiocystis pacifica SIR-1-reb7 Ruegeria pomeroyi DSS3-reb2 Pseudomonas fluorescens NEP1-reb2 Chromobacterium violaceum ATCC 12472-reb5 Plesiocystis pacifica SIR-1-reb2 Chromobacterium violaceum ATCC Polymorphum 12472-reb6 gilvum SL003B-26A1-reb2 Ruegeria pomeroyi DSS3-reb1 Pseudomonas fluorescens A506-reb3 Pseudomonas antarctica BS2772-reb3 Bukholderia Bukholderia sp. CCGE1003-reb1 sp. CCGE1003-reb2 Pseudomonas palleroniana Pseudomonas BS3265-reb3 protegens pf5-reb3 Pseudomonas aeruginosa PA14-PA14_27630 Pseudomonas aeruginosa PA14-PA14_27640 Pseudomonas synxantha BS33R-reb3 Pseudomonas aeruginosa AR0440-reb1 Pseudomonas libanensis BS2975-reb3 Pseudomonas mucidolens LMG2223-reb3 Pseudomonas aeruginosa LESB58-reb2 Pseudomonas aeruginosa AR0440-reb2 Pseudomonas chlororaphis B25-reb3 Pseudomonas aeruginosa LESB58-reb1 Pseudomonas aeruginosa LESB58-reb3 Chromobacterium -
Étude Des Communautés Microbiennes Rhizosphériques De Ligneux Indigènes De Sols Anthropogéniques, Issus D’Effluents Industriels Cyril Zappelini
Étude des communautés microbiennes rhizosphériques de ligneux indigènes de sols anthropogéniques, issus d’effluents industriels Cyril Zappelini To cite this version: Cyril Zappelini. Étude des communautés microbiennes rhizosphériques de ligneux indigènes de sols anthropogéniques, issus d’effluents industriels. Sciences agricoles. Université Bourgogne Franche- Comté, 2018. Français. NNT : 2018UBFCD057. tel-01902775 HAL Id: tel-01902775 https://tel.archives-ouvertes.fr/tel-01902775 Submitted on 23 Oct 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITÉ DE BOURGOGNE FRANCHE-COMTÉ École doctorale Environnement-Santé Laboratoire Chrono-Environnement (UMR UFC/CNRS 6249) THÈSE Présentée en vue de l’obtention du titre de Docteur de l’Université Bourgogne Franche-Comté Spécialité « Sciences de la Vie et de l’Environnement » ÉTUDE DES COMMUNAUTES MICROBIENNES RHIZOSPHERIQUES DE LIGNEUX INDIGENES DE SOLS ANTHROPOGENIQUES, ISSUS D’EFFLUENTS INDUSTRIELS Présentée et soutenue publiquement par Cyril ZAPPELINI Le 3 juillet 2018, devant le jury composé de : Membres du jury : Vera SLAVEYKOVA (Professeure, Univ. de Genève) Rapporteure Bertrand AIGLE (Professeur, Univ. de Lorraine) Rapporteur & président du jury Céline ROOSE-AMSALEG (IGR, Univ. de Rennes) Examinatrice Karine JEZEQUEL (Maître de conférences, Univ. de Haute Alsace) Examinatrice Nicolas CAPELLI (Maître de conférences HDR, UBFC) Encadrant Christophe GUYEUX (Professeur, UBFC) Co-directeur de thèse Michel CHALOT (Professeur, UBFC) Directeur de thèse « En vérité, le chemin importe peu, la volonté d'arriver suffit à tout. -
Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea—A Systematic Review of the Literature
microorganisms Review Diversity and Composition of the Skin, Blood and Gut Microbiome in Rosacea—A Systematic Review of the Literature Klaudia Tutka, Magdalena Zychowska˙ and Adam Reich * Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-055 Rzeszow, Poland; [email protected] (K.T.); [email protected] (M.Z.)˙ * Correspondence: [email protected]; Tel.: +48-605076722 Received: 30 August 2020; Accepted: 6 November 2020; Published: 8 November 2020 Abstract: Rosacea is a chronic inflammatory skin disorder of a not fully understood pathophysiology. Microbial factors, although not precisely characterized, are speculated to contribute to the development of the condition. The aim of the current review was to summarize the rosacea-associated alterations in the skin, blood, and gut microbiome, investigated using culture-independent, metagenomic techniques. A systematic review of the PubMed, Web of Science, and Scopus databases was performed, according to PRISMA (preferred reporting items for systematic review and meta-analyses) guidelines. Nine out of 185 papers were eligible for analysis. Skin microbiome was investigated in six studies, and in a total number of 115 rosacea patients. Blood microbiome was the subject of one piece of research, conducted in 10 patients with rosacea, and gut microbiome was studied in two papers, and in a total of 23 rosacea subjects. Although all of the studies showed significant alterations in the composition of the skin, blood, or gut microbiome in rosacea, the results were highly inconsistent, or even, in some cases, contradictory. Major limitations included the low number of participants, and different study populations (mainly Asians). Further studies are needed in order to reliably analyze the composition of microbiota in rosacea, and the potential application of microbiome modifications for the treatment of this dermatosis. -
Burkdiff: a Real-Time PCR Allelic Discrimination Assay for Burkholderia Pseudomallei and B
BurkDiff: A Real-Time PCR Allelic Discrimination Assay for Burkholderia Pseudomallei and B. mallei Jolene R. Bowers1*, David M. Engelthaler1, Jennifer L. Ginther2, Talima Pearson2, Sharon J. Peacock3, Apichai Tuanyok2, David M. Wagner2, Bart J. Currie4, Paul S. Keim1,2 1 Translational Genomics Research Institute, Flagstaff, Arizona, United States of America, 2 Northern Arizona University, Flagstaff, Arizona, United States of America, 3 Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 4 Menzies School of Health Research, Darwin, Australia Abstract A real-time PCR assay, BurkDiff, was designed to target a unique conserved region in the B. pseudomallei and B. mallei genomes containing a SNP that differentiates the two species. Sensitivity and specificity were assessed by screening BurkDiff across 469 isolates of B. pseudomallei, 49 isolates of B. mallei, and 390 isolates of clinically relevant non-target species. Concordance of results with traditional speciation methods and no cross-reactivity to non-target species show BurkDiff is a robust, highly validated assay for the detection and differentiation of B. pseudomallei and B. mallei. Citation: Bowers JR, Engelthaler DM, Ginther JL, Pearson T, Peacock SJ, et al. (2010) BurkDiff: A Real-Time PCR Allelic Discrimination Assay for Burkholderia Pseudomallei and B. mallei. PLoS ONE 5(11): e15413. doi:10.1371/journal.pone.0015413 Editor: Frank R. DeLeo, National Institutes of Health, United States of America Received July 26, 2010; Accepted September 12, 2010; Published November 12, 2010 Copyright: ß 2010 Bowers et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. -
Comparative Analysis of the Core Proteomes Among The
Diversity 2020, 12, 289 1 of 25 Article Comparative Analysis of the Core Proteomes among the Pseudomonas Major Evolutionary Groups Reveals Species‐Specific Adaptations for Pseudomonas aeruginosa and Pseudomonas chlororaphis Marios Nikolaidis 1, Dimitris Mossialos 2, Stephen G. Oliver 3 and Grigorios D. Amoutzias 1,* 1 Bioinformatics Laboratory, Department of Biochemistry and Biotechnology, University of Thessaly, 41500 Larissa, Greece; [email protected] 2 Microbial Biotechnology‐Molecular Bacteriology‐Virology Laboratory, Department of Biochemistry and Biotechnology, University of Thessaly, 41500 Larissa, Greece; [email protected] 3 Cambridge Systems Biology Centre & Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK; [email protected] * Correspondence: [email protected]; Tel.: +30‐2410‐565289; Fax: +30‐2410‐565290 Received: 22 June 2020; Accepted: 22 July 2020; Published: 24 July 2020 Abstract: The Pseudomonas genus includes many species living in diverse environments and hosts. It is important to understand which are the major evolutionary groups and what are the genomic/proteomic components they have in common or are unique. Towards this goal, we analyzed 494 complete Pseudomonas proteomes and identified 297 core‐orthologues. The subsequent phylogenomic analysis revealed two well‐defined species (Pseudomonas aeruginosa and Pseudomonas chlororaphis) and four wider phylogenetic groups (Pseudomonas fluorescens, Pseudomonas stutzeri, Pseudomonas syringae, Pseudomonas putida) with a sufficient number of proteomes. As expected, the genus‐level core proteome was highly enriched for proteins involved in metabolism, translation, and transcription. In addition, between 39–70% of the core proteins in each group had a significant presence in each of all the other groups. Group‐specific core proteins were also identified, with P.